Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

References

• Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's Disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439–44.
   PubMed Web of Science ®Google Scholar
• Saverymuttu SH. Clinical remission in Crohn's disease–assessment using faecal 111In granulocyte excretion. Digestion 1986;33:74–9.
   PubMed Web of Science ®Google Scholar
• Hommes DW, van Deventer SJH. Endoscopy in inflammatory bowel diseases. Gastroenterology 2004;126:1561–73.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004;126:402–13.
   PubMed Web of Science ®Google Scholar
• Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif [GETAID]. Gut 1989;30:983–9.
   PubMed Web of Science ®Google Scholar
• Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505–12.
   PubMed Web of Science ®Google Scholar
• Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47:506–13.
   PubMed Web of Science ®Google Scholar
• Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450–60.
   PubMed Web of Science ®Google Scholar
• Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Faecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309–14.
   PubMed Web of Science ®Google Scholar
• Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50–4.
   PubMed Web of Science ®Google Scholar
• Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362–6.
   PubMed Web of Science ®Google Scholar
• Kristinsson J, Roseth A, Fagerhol MK, Aadland E, Schjonsby H, Bormer OP, Faecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998;41:316–21.
   PubMed Web of Science ®Google Scholar
• Shastri YM, Bergis D, Povse N, Schafer V, Shastri S, Weindel M, Prospective multicenter study evaluating faecal calprotectin in adult acute bacterial diarrhea. Am J Med 2008;121:1099–106.
   PubMed Web of Science ®Google Scholar
• Ruiz-Pelaez JG, Mattar S. Accuracy of faecal lactoferrin and other stool tests for diagnosis of invasive diarrhea at a Colombian pediatric hospital. Pediatr Infect Dis J 1999;18:342–6.
   PubMed Web of Science ®Google Scholar
• Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Farkkila M. Crohn's disease activity assessed by faecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008;14:40–6.
   PubMed Web of Science ®Google Scholar
• Jones J, Loftus EV Jr., Panaccione R, Chen LS, Peterson S, McConnell J, Relationships between disease activity and serum and faecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008;6:1218–24.
   PubMed Web of Science ®Google Scholar
• Ton H, Brandsnes, S, Holtlund J, Skuibina E, Schjonsby H, Improved assay for faecal calprotectin. Clin Chim Acta 2000;292:41–54.
   PubMed Web of Science ®Google Scholar
• Uchida K, Matsuse R, Tomita S, Sugi K, Saitoh O, Ohshiba S. Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer. Clin Biochem 1994;27:259–64.
   PubMed Web of Science ®Google Scholar
• Sipponen T, Savilahti E, Karkkainen P, Kolho KL, Nuutinen H, Turunen U, Faecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease. Inflamm Bowel Dis 2008;14:1392–8.
   PubMed Web of Science ®Google Scholar
• Moskovitz DN, Daperno M, Van Assche GA. Defining and validating cut-offs for the Simple Endocopic Score for Crohn's Disease. Gastroenterology 2007;132:A-S1097.
   Google Scholar
• Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn's disease: monitoring disease activity. Aliment Pharmacol Ther 2003;17(Suppl 2):11–17.
   PubMedGoogle Scholar
• Kolho KL, Raivio T, Lindahl H, Savilahti E. Faecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol 2006;41:720–5.
   PubMed Web of Science ®Google Scholar
• von Roon AC, Karamountzos L, Purkayastha S, Reese GE, Darzi AW, Teare JP, Diagnostic precision of faecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007;102:803–13.
   PubMed Web of Science ®Google Scholar
• Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793–8.
   PubMed Web of Science ®Google Scholar
• Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642–7.
   PubMedGoogle Scholar
• Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of faecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 2008;103:162–9.
   PubMed Web of Science ®Google Scholar
• Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F. Discriminating IBD from IBS: comparison of the test performance of faecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 2008;14:32–9.
   PubMed Web of Science ®Google Scholar
• Roseth AG, Aadland E, Grzyb K. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 2004;39:1017–20.
   PubMed Web of Science ®Google Scholar
• Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen A, Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis 2005;11:1085–91.
   PubMed Web of Science ®Google Scholar
• Aadland E, Fagerhol MK. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002;14:823–5.
   PubMed Web of Science ®Google Scholar
• Buderus S, Boone J, Lyerly D, Lentze MJ. Faecal lactoferrin: a new parameter to monitor infliximab therapy. Dig Dis Sci 2004;49:1036–9.
   PubMed Web of Science ®Google Scholar
• Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M. Faecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 2008;14:5584–9.
   PubMed Web of Science ®Google Scholar
• Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990;98:811–18.
   PubMed Web of Science ®Google Scholar
• Walker TR, Land ML, Kartashov A, Saslowsky TM, Lyerly DM, Boone JH, Faecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007;44:414–22.
   PubMed Web of Science ®Google Scholar